Fisher & Paykel Healthcare Corporation Limited (FSPKF) has released an update.
Fisher & Paykel Healthcare Corporation Limited’s director, Graham Andrew McLean, has reported the acquisition of 1,100 Ordinary Shares, marking a notable change in his beneficial interest in the company. The transaction, which took place on 21 June 2024 at a price of AUD 28.66 per share, is a singular event that has been disclosed to NZX Limited as per regulatory requirements.
For further insights into FSPKF stock, check out TipRanks’ Stock Analysis page.
